Of note, HOIP-mutated patients present with recurrent bacterial infections and hyper-inflammation,132 further supporting the potential therapeutic targets of RNF31 for suppressing TLR3-related inflammatory diseases. This evidence concerns the gene RNF31 and bacterial infectious disease.